Figure 5
Clonal and malignant THS cells are present in the blood of patients with L-CTCL. (A) THS cells were present in the blood of patients with CTCL with known blood involvement but absent in patients without evidence of peripheral blood disease. Representative patients are shown; a THS cell population has been confirmed in 16 patients with L-CTCL. (B) Blood THS cells were obscured by monocytes in some patients. Staining for CD3 in addition to CD4 was required to show these cells. (C) THS cells were uniformly clonal and malignant in patients with L-CTCL and identifiable malignant T-cell clones. Shown are 8 patients with L-CTCL with identifiable T-cell clones. THS cell populations (red) were present in all patients. Selective gating on THS cells showed that most were clonal malignant T cells. SSC-A indicates side-scatter area; FSC-H, forward-scatter height.

Clonal and malignant THS cells are present in the blood of patients with L-CTCL. (A) THS cells were present in the blood of patients with CTCL with known blood involvement but absent in patients without evidence of peripheral blood disease. Representative patients are shown; a THS cell population has been confirmed in 16 patients with L-CTCL. (B) Blood THS cells were obscured by monocytes in some patients. Staining for CD3 in addition to CD4 was required to show these cells. (C) THS cells were uniformly clonal and malignant in patients with L-CTCL and identifiable malignant T-cell clones. Shown are 8 patients with L-CTCL with identifiable T-cell clones. THS cell populations (red) were present in all patients. Selective gating on THS cells showed that most were clonal malignant T cells. SSC-A indicates side-scatter area; FSC-H, forward-scatter height.

Close Modal

or Create an Account

Close Modal
Close Modal